ABERA BIOSCIENCE AB (8WK) — Financial Flexibility Index
ABERA BIOSCIENCE AB (8WK) has a Financial Flexibility Index of -0.08x as of December 2025. Free cash flow of €-743.00K (operating CF €-815.00K minus capex €72.00K) represents 0% of total liabilities (€9.28 Million). Also explore net asset growth rate of ABERA BIOSCIENCE AB to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
ABERA BIOSCIENCE AB Financial Flexibility Index (2022–2025)
Historical Financial Flexibility Index trend for ABERA BIOSCIENCE AB across 4 annual periods. See ABERA BIOSCIENCE AB (8WK) balance sheet quality index to measure how much of total assets are equity-financed.
Annual Financial Flexibility Index for ABERA BIOSCIENCE AB (2022–2025)
Year-by-year free cash flow to debt coverage for ABERA BIOSCIENCE AB. For the full company profile including market capitalisation, see 8WK market cap.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.31x | €-2.83 Million | €-3.26 Million | €9.28 Million | ▼ -261.8% |
| 2024 | 0.19x | €933.00K | €-198.00K | €4.95 Million | ▲ +103.9% |
| 2023 | -4.80x | €-17.71 Million | €-17.71 Million | €3.69 Million | ▲ +31.9% |
| 2022 | -7.05x | €-19.69 Million | €-19.69 Million | €2.80 Million | — |